指南与共识癫痫

实践指南摘要:癫痫猝死发病率与危险因素

Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
指南 / 共识 · Neurology · 2017-01-01

该指南由美国神经病学学会与美国癫痫学会制定,基于系统评价和改良GRADE方法,明确了不同癫痫人群中SUDEP的发病率,并指出全面性强直-阵挛发作是主要危险因素,推荐临床医生向患者及家属告知风险并积极管理癫痫治疗。

要点

  • 儿童癫痫SUDEP风险为0.22/1000人年,成人增至1.2/1000人年。
  • 全面性强直-阵挛发作是SUDEP主要危险因素,频率增加风险升高。
  • 应告知家属儿童每年约1/4500受影响,成人每年约1/1000受影响。

核心结论

  • SUDEP风险在儿童癫痫中为0.22/1000人年,成人增至1.2/1000人年。
  • 全面性强直-阵挛发作是SUDEP的主要危险因素,其频率增加与风险升高相关。

研究设计与样本

  • 系统评价证据,采用改良GRADE流程形成结论,推荐通过共识制定。
  • 发病率基于12项Class I研究。

主要发现

  • 儿童癫痫(0-17岁)SUDEP风险为0.22/1000人年(95%CI 0.16-0.31),证据信心中等。
  • 成人SUDEP风险为1.2/1000人年(95%CI 0.64-2.32),证据信心低。
  • 全面性强直-阵挛发作频率增加与SUDEP风险升高相关,证据信心高。

关键数值与推荐

  • Level B推荐:应告知癫痫患儿父母/监护人,1年内SUDEP通常影响4500名儿童中的1名,即4500名中4499名不受影响。
  • Level B推荐:应告知成人癫痫患者,每年SUDEP通常影响1000名成人中的1名,即每年1000名中999名不受影响。
  • 对于仍有全面性强直-阵挛发作的癫痫患者,应继续积极管理癫痫治疗以减少发作和SUDEP风险,同时结合患者偏好并权衡新方案的风险与获益。
  • 应告知癫痫患者,无发作尤其无全面性强直-阵挛发作与SUDEP风险降低强烈相关。

临床怎么用

  • 临床医生应依据年龄向患者或家属告知SUDEP的典型年风险(儿童1/4500,成人1/1000)。
  • 对仍有全面性强直-阵挛发作的患者,应积极优化治疗以控制发作并降低SUDEP风险。
  • 应告知患者无发作尤其无全面性强直-阵挛发作可显著降低SUDEP风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the incidence rates of sudden unexpected death in epilepsy (SUDEP) in different epilepsy populations and address the question of whether risk factors for SUDEP have been identified. METHODS: Systematic review of evidence; modified Grading Recommendations Assessment, Development, and Evaluation process for developing conclusions; recommendations developed by consensus. RESULTS: Findings for incidence rates based on 12 Class I studies include the following: SUDEP risk in children with epilepsy (aged 0-17 years) is 0.22/1,000 patient-years (95% confidence interval [CI] 0.16-0.31) (moderate confidence in evidence). SUDEP risk increases in adults to 1.2/1,000 patient-years (95% CI 0.64-2.32) (low confidence in evidence). The major risk factor for SUDEP is the occurrence of generalized tonic-clonic seizures (GTCS); the SUDEP risk increases in association with increasing frequency of GTCS occurrence (high confidence in evidence). RECOMMENDATIONS: Level B: Clinicians caring for young children with epilepsy should inform parents/guardians that in 1 year, SUDEP typically affects 1 in 4,500 children; therefore, 4,499 of 4,500 children will not be affected. Clinicians should inform adult patients with epilepsy that SUDEP typically affects 1 in 1,000 adults with epilepsy per year; therefore, annually 999 of 1,000 adults will not be affected. For persons with epilepsy who continue to experience GTCS, clinicians should continue to actively manage epilepsy therapies to reduce seizures and SUDEP risk while incorporating patient preferences and weighing the risks and benefits of any new approach. Clinicians should inform persons with epilepsy that seizure freedom, particularly freedom from GTCS, is strongly associated with decreased SUDEP risk.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Harden C, Tomson T, Gloss D, et al. Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2017. PMID: 28438841. doi:10.1212/WNL.0000000000003685

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。